Results

Total Results: 3,881 records

Showing results for "phase".

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-screening-2002
    September 03, 2002 - the searches identified 146 controlled trials, of which 132 were excluded at the title and abstract phase
  3. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
    March 08, 2004 - hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase
  4. cdsic.ahrq.gov/sites/default/files/2023-08/Final%20TPC%20P3_Source%20Credibility%20to%20AHRQ%208.2.23_508c%20Version.pdf
    January 01, 2023 - Following de-duplication, 63 articles underwent a two- phase screening process.
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - Phase III randomized study of tamoxifen and raloxifene (STAR) for the prevention of breast cancer. 2004
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
    August 23, 2012 - rate in the group that used N2O (11.6% vs 19.3% Cesarean rates, P < 0.05and 153 min vs 187 min active phase
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
    December 01, 2012 - Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer Technical Brief Number 13 Technical Brief Number 13 Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer …
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
    February 01, 2012 - Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=971 Published Online: February 2012 Comparative Effectiveness Re…
  9. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/system/systemredesignsafetynet/systemredesign.pdf
    June 01, 2015 - System Redesign Responses to Challenges in Safety-Net Systems System Redesign Responses to Challenges in Safety-Net Systems: Summary of Field Study Research Submitted to: Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 www.ahrq.gov AHRQ ACTION II Contract No. H…
  10. www.ahrq.gov/practiceimprovement/systemdesign/leancasestudies/lean-case1.html
    November 01, 2014 - After the 30-day report, the project enters what LHC terms the "control" phase, the goal of which is
  11. hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR-User-Guide-v2025-1.pdf
    November 01, 2024 - User Guide (v2025.1) for Clinical Classifications Software Refined (CCSR) for ICD-10-PCS USER GUIDE: CLINICAL CLASSIFICATIONS SOFTWARE REFINED (CCSR) FOR ICD-10-PCS PROCEDURES, v2025.1 Issued November 2024 Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) Phone: (866)…
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
    November 01, 2013 - these choices considering the input of key informants, including patients, during the topic refinement phase
  13. digital.ahrq.gov/sites/default/files/docs/citation/QualityOralHealthCareMedicaid.pdf
    January 01, 2016 - Quality Oral Health Care in Medicaid Through Health IT F I N A L R E P O R T Quality Oral Health Care in Medicaid Through Health IT SEPTEMBER 2011 PRESENTED TO: Agency for Healthcare Research and Quality PRESENTED BY: NORC at the University of Chicago 4350 East West Highway 8th Floo…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
    December 15, 2015 - page 9, line 34, these terms are used to describe the form of the HIE, and are accompanied by the phase
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
    December 06, 2016 - We are currently in the validating and testing phase for our performance measures.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
    January 01, 2013 - Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests ! ! Methods Research Report Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Met…
  17. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy1/Strat1_Implement_Hndbook_508_v2.docx
    January 28, 2011 - Strategy 1: Working with Patients & Families as Advisors (Implementation Handbook) Working With Patient and Families as Advisors Implementation Handbook Strategy 3: Bedside Shift Report (Implementation Handbook) [Type text] [Type text] [Type text] Strategy 1: Working With Patient and Families as Advisors (Implementat…
  18. digital.ahrq.gov/sites/default/files/docs/publication/2014-jason-data-for-individual-health.pdf
    January 01, 2014 - To be sure, the FHIR system is now only in a demonstration phase, but with a concerted effort to standardize
  19. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
    July 15, 2007 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Lipid Disorders in Children: Screening July 15, 2007 Recommendations made by the USPSTF are independent of the U.S. government. They shou…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase